Dr. Gulhati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany Street
New Brunswick, NJ 08901Phone+1 732-235-3551Fax+1 732-235-6797
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2013 - 2016
University of Texas Medical Branch School of MedicineClass of 2013
Certifications & Licensure
NJ State Medical License 2019 - 2025
TX State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 443 citationsmTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathwaysPat Gulhati, Kanika A. Bowen, Jianyu Liu, Payton D. Stevens, Piotr G. Rychahou
Cancer Research. 2011-05-01 - 201 citationsNovel Expression Patterns of PI3K/AKT/mTOR Signaling Pathway Components in Colorectal CancerSara M. Johnson, Pat Gulhati, Bill A. Rampy, Yimei Han, Piotr G. Rychahou
Journal of the American College of Surgeons. 2010-05-01 - 122 citationsCurcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.Sara M. Johnson, Pat Gulhati, Isela Arrieta, Xiaofu Wang, Tatsuo Uchida
Anticancer Research. 2009-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
